Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial - van Es, R F; Jonker, J JC; Verheugt, F WA; Deckers, J W; Grobbee, D E; Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group (Lancet, 2002)
(9327):